Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
Twelve hospitals across India will be part of the network which will support the trial in India
Lenalidomide is used to treat various types of cancers.
Subscribe To Our Newsletter & Stay Updated